T1
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
T14.SI · SES
$2.52 -1.18% (-$0.03)
1M -6.93%
Market Cap ¥21.9B
P/E Ratio 25.80x
Div. Yield 27.39%
ROE 11.46%
Bulios Fair Price
$2.87
13.9% upside
Trenutna cena
$2.52
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica T14.SI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
40 /100
Fair P/B 3.68x
P/S 4.64x
P/E 25.80x
Growth
34 /100
Stable Book val. growth 2.87%
FCF growth 15.59%
EPS growth 35.64%
Profitability
91 /100
Strong FCF margin 16.49%
Op. margin 18.57%
Gross margin 74.46%
Quality
59 /100
Average Asset turnover 0.45x
ROA 8.04%
ROIC 12.37%
Debt
95 /100
Low Net debt/EBITDA -2.36x
Int. coverage 100.77x
Debt/Equity 0.02x
Stability
59 /100
Moderate Profitable years 6
EPS volatility 70.64%
Beta 0.52x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o T14.SI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lei Wang
Employees
3,890
Headquarters
Tianjin